EIV Capital
19
21M
17
1.36
11
0.11
2
- Stages of investment
- Areas of investment
Summary
EIV Capital is the famous VC, which was founded in 2009. The leading representative office of defined VC is situated in the Houston. The venture was found in North America in United States.
The important activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from EIV Capital is 10-50 millions dollars. Considering the real fund results, this VC is 63 percentage points more often commits exit comparing to other organizations.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Glycos Biotechnologies. Among the most popular fund investment industries, there are Biotechnology, Energy.
This organization was formed by Anthony Annunziato. Besides them, we counted 5 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the EIV Capital, startups are often financed by DFJ, Mercury Fund. The meaningful sponsors for the fund in investment in the same round are Mercury Fund, Gideon Hixon Fund, Draper Nexus Ventures. In the next rounds fund is usually obtained by Mercury Fund, DFJ.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 11
- Exits
- 2
- Rounds per year
- 1.36
- Follow on index
- 0.11
- Investments by industry
- Oil and Gas (14)
- Energy (12)
- Renewable Energy (5)
- Biotechnology (2)
- Chemical (2) Show 14 more
- Investments by region
-
- United States (19)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 0.11
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.27
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Glycos Biotechnologies | 20 Oct 2010 | Biotechnology, Renewable Energy, Chemical | Early Stage Venture | 4M | United States, Texas, Houston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.